S.61 - Safe and Affordable Drugs from Canada Act of 2019116th Congress (2019-2020) |
|Sponsor:||Sen. Grassley, Chuck [R-IA] (Introduced 01/09/2019)|
|Committees:||Senate - Health, Education, Labor, and Pensions|
|Latest Action:||Senate - 01/09/2019 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (All Actions)|
This bill has the status Introduced
Here are the steps for Status of Legislation:
- Passed Senate
- Passed House
- To President
- Became Law
Summary: S.61 — 116th Congress (2019-2020)All Information (Except Text)
Introduced in Senate (01/09/2019)
Safe and Affordable Drugs from Canada Act of 2019
This bill requires the Food and Drug Administration (FDA) to promulgate regulations within 180 days permitting individuals to import a prescription drug purchased from an approved Canadian pharmacy if the drug
- is dispensed by a pharmacist licensed in Canada;
- is purchased for personal use in quantities not greater than a 90-day supply;
- is filled using a valid prescription issued by a physician licensed to practice in the United States; and
- has the same active ingredients, route of administration, dosage form, and strength as a prescription drug approved by the FDA.
Under the bill, certain drugs may not be imported, including controlled substances and biological products.
The bill establishes a certification process for approving Canadian pharmacies. The FDA must publish a list of approved Canadian pharmacies.